Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Previous studies suggest that insulin-sensitizing agents could play a significant role in the treatment of major depression, particularly depression in patients with documented insulin resistance or those who are resistant to standard psychopharmacological approaches. This study aimed to assess the effects on depressive symptoms with adjuvant treatment with the PPARγ-agonist pioglitazone. Patients (N=37) with non-psychotic, non-remitting depression receiving standard psychiatric regimens for depression were randomized across an insulin sensitivity spectrum in a 12-week double blind, randomized controlled trial of pioglitazone or placebo. Improvement in depression was associated with improvement in glucose metabolism but only in patients with insulin resistance. An age effect was also shown in that response to pioglitazone was more beneficial in younger aged patients. Study findings suggest differential improvement in depression severity according to both glucose metabolic status and level of depression at baseline. A greater understanding of the reciprocal links between depression and IR may lead to a dramatic shift in the way in which depression is conceptualized and treated, with a greater focus on treating and/or preventing metabolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 3×
“An increase in pro-inflammatory cytokines is common in depression, obesity, metabolic syndrome, and DM2, due to activation of the glutamatergic system, resulting in a reduction of glutamate re-uptake (Raison et al., 2006).”
The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · cited 1×
“…features of inflammation, including elevations in relevant inflammatory cytokines and their soluble receptors in peripheral blood and cerebrospinal fluid, as well as elevations in peripheral blood concentrations of acute phase proteins and chemokines (Zorrilla et al., 2001; Raison et al., 2006).”
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735 · cited 3×
“Further, depressed patients with evidence of increased inflammatory activity prior to treatment have been reported to be less responsive to antidepressants, or lithium (Sluzewska et al., 1997; Lanquillon et al., 2000), suggesting that reducing inflammation may result in enhanced antidepressant response.”
A prospective evaluation of the directionality of the depression–inflammation relationship
Stewart, J. C., Rand, K. L., Muldoon, M. F., & Kamarck, T. W. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.011 · Cited by 390
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
Thase, M. E., Entsuah, R., Cantillon, M., & Kornstein, S. G. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.609 · Cited by 201
Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.08.010 · Cited by 116 · cited 3×
“Studies that found depression treatment response of pioglitazone in patients either with or without impaired glucose metabolism used younger samples (Sepanjnia et al., 2012; Kashani et al., 2013; Kemp et al., 2014) or did not specifically examine age effects.”
Kemp, D. E., Ismail-Beigi, F., Ganocy, S. J., Conroy, C., Gao, K., Obral, S., Fein, E., Findling, R. L., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.033 · Cited by 109 · cited 3×
“Treatment with pioglitazone has also been shown to be successful in bipolar patients with unremitting depression and metabolic syndrome (Rasgon et al., 2010; Kemp et al., 2012).”
Evidence that the brain of the conscious dog is insulin sensitive.
Davis, S. N., Colburn, C., Dobbins, R., Nadeau, S., Neal, D., Williams, P., & Cherrington, A. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117703 · Cited by 68 · cited 3×
“…debate, it is clear that insulin has multiple functions within the CNS. Insulin has been shown to affect the release and reuptake of catecholamines and influence the regulation of regional cerebral blood flow, the autonomic nervous system, and the HPA axis (Kerr et al., 1993; Davis et al., 1995).”
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Cited by
Köhler‐Forsberg, O., N. Lydholm, C., Hjorthøj, C., Nordentoft, M., Mors, O., & Benros, M. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13016 · Cited by 432
Wójtowicz, S., Strosznajder, A. K., Jeżyna, M., & Strosznajder, J. B. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02993-5 · Cited by 327
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
Cheng, H. S., Tan, W. R., Low, Z. S., Marvalim, C., Lee, J. Y. H., & Tan, N. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205055 · Cited by 264
Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
Lyra e Silva, N. D. M., Lam, M. P., Soares, C. N., Munoz, D. P., Milev, R., & De Felice, F. G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00057 · Cited by 164
“Interestingly, pioglitazone effectiveness was age-dependent, being more efficacious in younger subjects (107).”
BackgroundAcetyl- l -carnitine deficiency in patients with major depressive disorder
Nasca, C., Bigio, B., Lee, F. S., Young, S. P., Kautz, M. M., Albright, A., Beasley, J., Millington, D. S., Mathé, A. A., Kocsis, J. H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801609115 · Cited by 152
Self-citation
Metadata
- Authors
- Lin, K. W., Wroolie, T. E., Robakis, T., & Rasgon, N. L.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 230
- Issue
- 3
- Pages
- 846-852
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W1866846039
- Cited by
- 80
- References
- 11
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.